National Research (NASDAQ:NRC) Rating Lowered to Hold at BidaskClub

BidaskClub lowered shares of National Research (NASDAQ:NRC) from a buy rating to a hold rating in a research note issued to investors on Tuesday, BidAskClub reports.

Separately, ValuEngine upgraded shares of National Research from a sell rating to a hold rating in a report on Tuesday, February 4th.

Shares of NASDAQ NRC opened at $68.92 on Tuesday. The company has a quick ratio of 0.69, a current ratio of 0.69 and a debt-to-equity ratio of 1.07. The firm’s fifty day moving average is $67.79 and its 200 day moving average is $60.52. The company has a market cap of $1.73 billion, a price-to-earnings ratio of 56.49 and a beta of 0.77. National Research has a 52 week low of $37.57 and a 52 week high of $71.35.

National Research (NASDAQ:NRC) last issued its quarterly earnings data on Tuesday, February 11th. The company reported $0.34 earnings per share (EPS) for the quarter. The business had revenue of $32.62 million for the quarter. National Research had a net margin of 25.01% and a return on equity of 130.25%.

In other news, major shareholder Amandla Mk Trust sold 22,160 shares of the business’s stock in a transaction on Tuesday, February 4th. The shares were sold at an average price of $70.13, for a total transaction of $1,554,080.80. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Barbara Mowry sold 3,215 shares of the business’s stock in a transaction on Monday, November 18th. The shares were sold at an average price of $62.83, for a total transaction of $201,998.45. Following the sale, the director now owns 16,458 shares in the company, valued at approximately $1,034,056.14. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 65,535 shares of company stock worth $4,396,088. Company insiders own 4.50% of the company’s stock.

Hedge funds have recently made changes to their positions in the company. Victory Capital Management Inc. boosted its stake in National Research by 9.9% in the 4th quarter. Victory Capital Management Inc. now owns 1,969 shares of the company’s stock worth $130,000 after purchasing an additional 178 shares in the last quarter. Strs Ohio boosted its stake in National Research by 1.8% in the 4th quarter. Strs Ohio now owns 11,600 shares of the company’s stock worth $764,000 after purchasing an additional 200 shares in the last quarter. California State Teachers Retirement System boosted its stake in National Research by 1.2% in the 3rd quarter. California State Teachers Retirement System now owns 18,745 shares of the company’s stock worth $1,083,000 after purchasing an additional 224 shares in the last quarter. Rhumbline Advisers boosted its stake in National Research by 1.8% in the 3rd quarter. Rhumbline Advisers now owns 15,029 shares of the company’s stock worth $868,000 after purchasing an additional 270 shares in the last quarter. Finally, FMR LLC boosted its stake in National Research by 106.5% in the 4th quarter. FMR LLC now owns 576 shares of the company’s stock worth $38,000 after purchasing an additional 297 shares in the last quarter. Hedge funds and other institutional investors own 39.60% of the company’s stock.

About National Research

National Research Corporation (NRC) is a provider of analytics and insights that facilitate revenue growth, patient, employee and customer retention and patient engagement for healthcare providers, payers and other healthcare organizations. The Company’s portfolio of subscription-based solutions provides information and analysis to healthcare organizations and payers across a range of mission-critical, constituent-related elements, including patient experience and satisfaction, community population health risks, workforce engagement, community perceptions, and physician engagement.

Read More: Is a Roth IRA right for you?

Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.